2020
- House of Representatives Standing Committee on Health, Aged Care and Sport inquiry into approval process for new drugs and novel medical technologies in Australia – November 2020 Sunday, 22 November 2020
- Medicines Australia submission to the Public Consultation – Revised Procedure Guidance – Public Summary Documents Friday, 25 September 2020
- Medicines Australia submission to the Public Consultation – Revised Procedure Guidance – Initial Submission Categories and Single Submission Date Friday, 25 September 2020
- Medicines Australia submission to the Public Consultation – Revised Procedure Guidance – Resubmission Pathways Friday, 25 September 2020
- Medicines Australia submission on the TGA consultation on export of therapeutic goods from Australia Friday, 25 September 2020
- Submission – Treasury Laws Amendment (Research and Development Tax Incentive) Bill 2019 Friday, 25 September 2020
- Medicines Australia Submission – Department of Health Lung Cancer Screening consultation Friday, 25 September 2020
- Submission – COVID-19 – Submission 233 Friday, 25 September 2020
- Submission – Inquiry into the implications of the COVID-19 pandemic for Australia’s foreign affairs, defence and trade Friday, 25 September 2020
- Submission – Inquiry into supporting Australia’s exports and attracting investment Friday, 25 September 2020
- Medicines Australia Federal Budget Submission 2020-2021 Wednesday, 29 July 2020
- Medicines Australia Federal Budget 2020-2021 Infographic Wednesday, 29 July 2020
- Medicines Australia submission to the Draft Cost Recovery Implementation Statement (CRIS) for Listing Medicines on the PBS and Designated Vaccines on the NIP 1 July 2020 – 30 June 2021 Saturday, 25 July 2020
- Medicines Australia submission to the Draft Cost Recovery Implementation Statement (CRIS) for Listing Medicines on the PBS and Designated Vaccines on the NIP 1 July 2020 – 30 June 2021 (June 2020) Thursday, 25 June 2020
- Medicines Australia’s submission to the final report of the Chronic Plaque Psoriasis Cost‐Effectiveness Review (June 2020) Thursday, 25 June 2020
- Medicines Australia and members’ response to the proposed new policy on rescinding Pharmaceutical Benefits Advisory Committee positive recommendations (June 2020) Thursday, 25 June 2020
- Medicines Australia Summary of comments re: moving all existing and future Special Pricing Agreement deeds of agreement to monthly invoicing (June 2020) Monday, 22 June 2020
- Medicines Australia Submission to TGA Scope of Regulated Software (May 2020) Monday, 25 May 2020
- Medicines Australia’s Response to Public Summary Documents (PSD) Process (April 2020) Saturday, 25 April 2020
- Medicines Australia OIT Cancer submission (March 2020) Wednesday, 25 March 2020
- Medicines Australia submission to the Draft Cost Recovery Implementation Statement (CRIS) for Listing Medicines on the PBS and Designated Vaccines on the NIP 1 July 2020 – 30 June 2021 (March 2020) Wednesday, 25 March 2020
- Medicines Australia response to the Draft Cost Recovery Impact Statement (CRIS) for Listing Medicines on the PBS and Designated Vaccines on the NIP 2019-20 Wednesday, 25 September 2019